Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fuminari Fujii
Institution:
Kameda Medical Center
Observed institutions:
Okayama University Hospital,
Kameda Medical Center
ORCID:
0009-0002-9641-3602
Observed ORCID:
0009-0002-9641-3602
OpenAlex ID:
A5111281403
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma
2024
·
Daisuke Ikeda
, Shuichi Aikawa
, et al.
·
Blood
·
21
Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
2025
·
Masanori Toho
, Daisuke Ikeda
, et al.
·
Haematologica
·
5
PDF
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia
2025
·
Mitsuaki Oura
, Daisuke Ikeda
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
4
Efficacy and relapse profiles of Pola‐R‐ CHP versus R‐ CHOP in previously untreated diffuse large B‐cell lymphoma: A multicentre real‐world study
2025
·
Toshiki Terao
, Isao Yoshida
, et al.
·
British Journal of Haematology
·
3
[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation].
2024
·
Fuminari Fujii
, Toshiki Terao
, et al.
·
PubMed
·
3
Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton’s tyrosine kinase inhibitor and bispecific antibody therapy
2026
·
Mitsuaki Oura
, Masanori Toho
, et al.
·
Frontiers in Oncology
·
2
PDF
Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma
2024
·
Atsushi Uehara
, Fuminari Fujii
, et al.
·
Blood
·
2
Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses
2024
·
Rikako Tabata
, Mitsuaki Oura
, et al.
·
Blood
·
2
Total Diffusion Volume Evaluated By Whole-Body Diffusion Weighted Magnetic Resonance Image for the Assessment of Tumor Burden in Multiple Myeloma; Relations with Measurable Residual Disease Evaluated By Next-Generation Flow Cytometry and Bone Marrow CD138 Staining Assessed By Qupath
2024
·
Kentaro Narita
, Youichi Machida
, et al.
·
Blood
·
2
PDF
Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma
2024
·
Daisuke Ikeda
, Shuichi Aikawa
, et al.
·
Blood
·
1
Soluble BCMA Defines Spatial Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma
2026
·
Masanori Toho
, Rikako Tabata
, et al.
·
Blood
Treatment‐specific differences in soluble B‐cell maturation antigen levels at minimum residual disease negativity in multiple myeloma
2026
·
Masanori Toho
, Rikako Tabata
, et al.
·
British Journal of Haematology
Impact of the plasma cell quantification method on the International Myeloma Working Group diagnostic criteria for MGUS/SMM
2025
·
Atsushi Uehara
, Hajime Sakuma
, et al.
·
Haematologica
PDF
Distinct immunophenotypic profiles of circulating tumor plasma cells in MGUS and smoldering multiple myeloma
2025
·
Atsushi Uehara
, Kentaro Narita
, et al.
·
International Journal of Hematology
Tracking MRD in multiple myeloma: Soluble BCMA reflects flow cytometry changes
2025
·
Masanori Toho
, Rikako Tabata
, et al.
·
Blood
Radiomic features from PET-CT enable diagnostic and prognostic stratification in peripheral T-cell lymphoma
2025
·
Hajime Sakuma
, Daisuke Ikeda
, et al.
·
Blood
PDF
Clinical and radiological prediction models for random skin biopsy positivity in suspected intravascular large B-cell lymphoma: development and internal validation
2025
·
Hajime Sakuma
, Kentaro Narita
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia
2024
·
Mitsuaki Oura
, Daisuke Ikeda
, et al.
·
Blood
Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach
2024
·
Fuminari Fujii
, Daisuke Ikeda
, et al.
·
Blood
Show more works
View as search
Works count:
19
Citation count:
45
H-index:
3
I10-index:
1
Year
Topic
Type